Spinal meeting highlights growing interest in nonfusion
This article was originally published in Clinica
Executive Summary
The fifth annual meeting of the Spine Arthroplasty Society was held in New York on May 4-7 2005. This exclusive report for Clinica is by US merchant banking firm Viscogliosi Bros, which helped fund and set up the society in 2001 to provide a focus for non-fusion and minimally invasive approaches to treating degenerative disc disease and lower back problems
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.